Savient Pharmaceuticals Seeks Bankruptcy Court OK For Deal Allowing $2.06M Claim

Savient Pharmaceuticals Seeks Bankruptcy Court OK For Deal Allowing $2.06M Claim

WILMINGTON, Del. - Bankrupt Savient Pharmaceuticals Inc. on Dec. 18 moved in the U.S. Bankruptcy Court for the District of Delaware for approval of a global settlement agreement that would allow its landlord to assert a claim against the bankruptcy estate for $2,062,000 in exchange for an agreement to terminate the lease for the company's headquarters (In Re: Savient Pharmaceuticals Inc., No. 13-12680, Chapter 11, D. Del. Bkcy.).

Find full version on lexis Advance®
Access this news story on lexis.com®